Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease

NCT01538329 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

210

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Amantadine
DRUG: placebo

Sponsor

University Hospital, Toulouse